NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Sintx Technologies, Inc. (SINT) Stock Analysis

Sintx Technologies, Inc. (SINT) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

SINT

$1.74

+$0.02 (+1.16%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SINT with… →

SINT Key Statistics

As of Oct 21, 2026
Trading
Open
$1.70
Previous Close
$1.72
Day's Range
1.70–1.78
52-Week Range
1.40–4.46
Volume
20.13K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.59
Valuation
Market Cap
$13.15M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
9.89
EPS (ttm)Profit attributable to each share over the last twelve months.
−4.91
Financials (FY)
Revenue (FY)
$729.00K−41.49%
Net Income (FY)
−$10.36M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
7.56M
1-Year Return
−50.00%
Dividend and dates
Avg Volume
116.49K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, SINT closed at $1.74, −50.00% over 1 year.

Sintx Technologies, Inc. (SINT) has a market capitalization of $13.15M.

In fiscal 2025, SINT reported revenue of $729.00K.

SINT Stock Return by Calendar Year

Sintx Technologies, Inc. (SINT) 10-year return: what $10,000 became

1 year
$10,000 $5,000
−50.00%
5 years
$10,000 $0.69
−99.99%
10 years
$10,000 $0.003
−99.99997%

If you had invested $10,000 in Sintx Technologies, Inc. (SINT) 10 years ago, at the close on October 21, 2016, it would have been worth $0.003 at the close on October 21, 2026: −99.99997% in total, −77.66% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−54.92%
2025+10.29%
2024−95.41%
2023−96.06%
2022−84.92%
2021−59.11%
2020+5.37%
2019−72.41%
2018−94.50%
2017−56.75%
2016 (partial year)−24.10%

As of October 21, 2026.

SINT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$729.00K−$10.36M−1,421.7%
2024$1.25M−$11.02M−884.8%
2023$1.23M−$8.26M−673.7%
2022$601.00K−$12.04M−2,003.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$729.00K$172.00K−$10.72M−$10.36M−1,421.7%
2024$1.25M$435.00K−$9.04M−$11.02M−884.8%
2023$1.23M$442.00K−$13.36M−$8.26M−673.7%
2022$601.00K$336.00K−$11.34M−$12.04M−2,003.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SINT Valuation vs Medical Devices Median

Median of 145 stocks
MetricSINTMedical Devices medianvs median
P/S ratio9.892.533.9x the median

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 10 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Sintx Technologies, Inc. (SINT) at $13.15M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 32 employees.

The most recent close on file for SINT is $1.74, dated October 21, 2026. That is +$0.02 (+1.16%) against the previous close. Over the past 52 weeks the price has ranged from $1.40 to $4.46. The latest close sits 24.29% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $729.00K. That is −41.49% against the prior fiscal year, when revenue was $1.25M. The same year closed with a net loss of $10.36M. Earnings per share on a trailing basis come to −4.91.

Across the 4 fiscal years on file, revenue moves from $601.00K in 2022 to $729.00K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 9.89 times revenue. On price-to-sales that is 3.9 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −50.00%. Measured over 10 years, that is −77.66% a year compounded. Beta against the wider market is reported at 0.59. Daily returns over the trailing 10 years annualize to a volatility of 150.85%.

Growth & Income

The record shows no dividend for SINT.

Across the complete calendar years on file, 2025 returned +10.29% and 2023 returned −96.06%. Of the 9 complete calendar years on file, 2 finished higher. 2026 is still running; the total return is −54.92% year to date.

Peer Comparison

Sintx Technologies, Inc. (SINT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Sintx Technologies, Inc. SINT $13.15M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Sintx Technologies, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Sintx Technologies, Inc.

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Visit website →